Movement-Based Digital Game Intervention: The intervention consists of a 10-week movement-based digital game program specifically developed for children aged 6-10 years. Participants in the intervention groups will attend two sessions per week, with each session lasting approximately 60 minutes. Sessions include warm-up, movement-based digital game activities, and cool-down. The digital games are delivered using an interactive projection system and require children to perform active body movements in response to visual and game-based tasks. Activities progressively target balance, coordination, locomotor skills, object control, hand-eye coordination, bilateral coordination, rhythm, reaching, jumping, changing direction, body awareness, and target-directed movements. Game difficulty and movement demands are progressively adjusted throughout the intervention period.
Study summary
The goal of this study is to learn how artificial intelligence-supported digital games and exercise activities affect children with autism spectrum disorder and typically developing children aged 6 to 10 years. The main questions it aims to answer are:
Do the digital game and exercise activities improve children's motor skills? Do the activities affect repetitive behaviors, working memory, and brain activity?
Researchers will compare children who take part in the digital game and exercise activities with children who do not take part in these activities.
Participants will complete assessments before and after the study. Children in the intervention group will take part in artificial intelligence-supported digital game and exercise activities. Researchers will assess children's motor skills, working memory, behaviors, and brain activity.
Eligibility
Sex
ALL
Min age
6 Years
Max age
10 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Children aged 6-10 years.
* Written informed consent from a parent or legal guardian.
* Ability to understand and follow simple verbal instructions.
* Ability to stand independently and perform basic locomotor movements.
* For participants in the ASD groups: a physician-confirmed diagnosis of autism -spectrum disorder (ASD) with mild to moderate severity.
* For typically developing participants: typical development without a diagnosis of ASD or another neurodevelopmental disorder.
* For typically developing participants: no known neurological, orthopedic, or cardiovascular condition that would interfere with participation in the study activities.
Exclusion Criteria:
* Orthopedic surgery within the previous 6 months.
* Presence of a neurological, orthopedic, or cardiovascular condition that may limit participation in movement-based activities.
* An acute health condition that prevents participation in physical activity.
* For typically developing participants: presence of a diagnosed neurodevelopmental disorder.
* Inability to complete the planned assessments or participate safely in the study activities.
* For participants assigned to an intervention group: expected attendance of less than 80% of the planned intervention sessions.
Primary outcome measure(s)
Motor Skill Performance — Baseline and immediately after the 10-week intervention Motor proficiency in the 30 children with autism spectrum disorder and 30 typically developing children will be assessed using the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition, Short Form (BOT-2 SF).
The BOT-2 SF consists of 12 items representing eight motor skill areas: Fine Motor Precision, Fine Motor Integration, Manual Dexterity, Bilateral Coordination, Balance, Running Speed and Agility, Upper-Limb Coordination, and Strength. Raw performance scores for individual items are converted to point scores according to the BOT-2 scoring procedures and summed to obtain a Total Point Score.
The BOT-2 SF Total Point Score ranges from 0 to 88. Higher scores indicate better overall motor proficiency, whereas lower scores indicate poorer motor proficiency.
Repetitive Behaviors Assessed With the TEDÖ-R-TV — Baseline and immediately after the 10-week intervention Repetitive behaviors in the 30 children with autism spectrum disorder will be assessed using the Repetitive Behavior Scale-Revised-Turkish Version (RBS-R-TV). The scale consists of 43 items covering six domains of repetitive behavior: Stereotyped Behavior, Self-Injurious Behavior, Compulsive Behavior, Ritualistic Behavior, Sameness Behavior, and Restricted Behavior. Each item is rated on a 4-point scale from 0 to 3. The total score ranges from 0 to 129. Higher scores indicate greater severity of repetitive behaviors and, therefore, a worse outcome, whereas lower scores indicate less severe repetitive behaviors.
Working Memory Assessed With the Working Memory Scale (ÇBÖ) — Baseline and immediately after the 10-week intervention Working memory will be assessed using the Working Memory Scale (ÇBÖ) developed by Ergül, Özgür-Yılmaz, and Demir. The Working Memory Scale for Children Aged 5-10 Years will be used to assess working memory performance in children with autism spectrum disorder and typically developing children. The scale consists of nine subtests grouped into four dimensions: Verbal Short-Term Memory (Digit Recall, Word Recall, and Nonword Recall), Visual Short-Term Memory (Pattern Matrix and Block Recall), Verbal Working Memory (Backward Digit Recall and First-Word Recall), and Visual Working Memory (Odd-One-Out and Spatial Discrimination). Each item includes two trials, and one point is awarded for each sequence correctly recalled or identified in the required order. The total raw score ranges from 0 to 86, with higher scores indicating better working memory performance.
Brain Activity Assessed With Electroencephalography (EEG) — Baseline and immediately after the 10-week intervention Brain activity will be assessed using electroencephalography (EEG) before and after the intervention. EEG recordings will be used to evaluate changes in brain activity associated with the artificial intelligence-supported digital game and exercise intervention.
Trial sites (1)
Facility
City
Region
Status
Burdur Mehmet Akif Ersoy University
Burdur
Burdur
More Burdur Mehmet Akif Ersoy University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.